<DOC>
	<DOC>NCT00213798</DOC>
	<brief_summary>The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.</brief_summary>
	<brief_title>Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis. No lung instability. Individuals give all informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>plasma DNA</keyword>
	<keyword>allelotyping</keyword>
	<keyword>follow-up</keyword>
	<keyword>Prospective Study</keyword>
	<keyword>Non-Small Cell Lung Cancer</keyword>
	<keyword>Small Cell Lung Cancer</keyword>
</DOC>